CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
October 25th 2019
A two-time cancer survivor learns more about pancreatic cysts and discusses the value and cautions of genetic testing.
October 21st 2019
Cutaneous squamous cell carcinoma, caused by sun exposure or environmental toxins, is usually curable with surgery. Maybe that’s why many don’t realize that, if this cancer goes unchecked and untreated, it can grow, spread and become life-threatening.
October 5th 2019
A cancer survivor and clutter-clearing author shares autumnal time management tips.
September 29th 2019
One in two patients with metastatic melanoma is alive five years following treatment with Opdivo plus Yervoy, according to long-term follow-up of the phase 3 CheckMate 067 trial.
September 27th 2019
A two-time cancer survivor discusses her recently-discovered pancreatic cysts.
September 21st 2019
This two-time cancer survivor and clutter-clearing author struggles more thoughtfully with clutter since cancer.
September 19th 2019
A recent survey showed that most Americans do not know what cutaneous squamous cell carcinoma is and how severe the disease can be if it advances.
September 14th 2019
A two-time cancer survivor explores her thoughts on aging.
September 12th 2019
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with a skin cancer survivor who has dealt with many recurrences over the last 30 years and tells others to “listen to your mother” and protect your skin from the sun.
August 30th 2019
Cancer can switch you to a different track but does not necessarily derail you, says a two-time cancer survivor.
August 24th 2019
Nine years out from breast cancer and four years out from her melanoma, this cancer survivor still combats her fatigue.
August 16th 2019
There I was with my freshly darkened skin in the mirror (after a beautiful day out in the sun). What was I thinking? Oh yeah, I wasn’t thinking.
August 15th 2019
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with a melanoma survivor about the importance of community and human connection to build hope after a cancer diagnosis.
August 9th 2019
From hereditary cancer risk among twins to study findings in squamous cell carcinoma, here’s what is making headlines in the cancer space this week.
August 2nd 2019
Figuring out whether to take targeted drugs or immunotherapy can be challenging for patients with metastatic melanoma that expresses a BRAF gene mutation, but there are rules of thumb that can help.
June 27th 2019
In this week’s episode of “CURE Talks Cancer,” we spoke with a melanoma survivor who wishes she knew at diagnosis what her cancer journey would do for her – not to her.
June 11th 2019
A nine-year breast cancer survivor and five-year melanoma survivor shares her thoughts on cancer survivorship with a side of mid-life crisis.
June 5th 2019
In a talk to people affected by melanoma, Michael McGrady described reassessing his values after cancer and how it changed the course of his life.
May 29th 2019
Following surgery with medication, combining immunotherapies or targeted drugs and adding radiation to immunotherapy can improve effectiveness in treating various stages of melanoma.
May 24th 2019
With greater longevity for survivors of melanoma comes the need to treat lingering side effects and monitor for cancer recurrences.
May 16th 2019
Immunotherapy may be giving hope to people living with rare skin cancer.
February 19th 2019
The Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) – an immunotherapy agent – for the treatment of patients with resected, high-risk, stage 3 melanoma.
February 7th 2019
Here are tips for fellow cancer survivors to clear out cancer paraphernailia but keep important medical records.
January 14th 2019
Two-time cancer survivor suggests a careful approach when researching your own cancer.
December 27th 2018
A web-based intervention may help reduce harmful UV exposure and skin cancer risk in young adults, according to recent research.
December 20th 2018
The Food and Drug Administration (FDA) granted accelerated approval to Keytruda (pembrolizumab) for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma, according to the agency.
November 16th 2018
Young patients diagnosed with posterior uveal melanoma may have similar, if not worse, prognoses compared with the overall patient population.
November 15th 2018
Patients with BRAF wild-type advanced melanoma saw a survival benefit after treatment with Opdivo (nivolumab) compared with the chemotherapy agent dacarbazine.